drugset / Trial / NCT00254189

Study Evaluating Effects of Levonorgestrel and Ethinyl Estradiol on Ovulation

NCT00254189

Phase 2 Completed 60 enrolled Wyeth is now a wholly owned subsidiary of Pfizer
Non-randomizedSingle-groupOpen-labelTreatment

Summary

To determine the ability of a monophasic oral contraceptives ("OC") regimen of Levonorgestrel ("LNG") 90 mg and Ethinyl Estradiol ("EE") 20 mg to inhibit ovulation during 84 days of continuous therapy.

Timeline

Start
2002-12
Primary completion
Completion
2004-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Levonorgestrel Small molecule 90 mg Oral
Subject ethinyl estradiol Small molecule 20 mg Oral

Indications